Experience
Sandoz Inc.
Boehringer Ingelheim International GmbH et al.
Successfully represented patent owner in post grant review (PGR) challenge related to Skyrizi®.
Sandoz Inc. v. Boehringer Ingelheim International GmbH et al., PGR2022-00037, PTAB, Judges Newman, Obermann, Worth
Sandoz, Inc. et al v. Pharmacyclics LLC
Pharmacyclics LLC; Janssen Biotech, Inc.
Sequenom, Inc. et al
Grünenthal GmbH et al. v. Alvogen Pine Brook, Inc. et al.
Grünenthal GmbH et al.
Mylan Pharmaceuticals Inc. et al. v. Biogen MA Inc. et al.
Biogen MA Inc. et al.
BioDelivery Sciences International, Inc. et al. v. Chemo Research, SL et al.
BioDelivery Sciences International, Inc. et al.
Robert Bosch GmbH et al.
BioDelivery Sciences International, Inc. et al. v. Alvogen PB Research & Development LLC et al.
BioDelivery Sciences International, Inc. et al.
Britax Child Safety, Inc. v. Nuna International BV et al.
Nuna International B.V.; Nuna Baby Essentials, Inc.
Due to international data regulations, we’ve updated our privacy policy. Click here to read our privacy policy in full.
We use cookies on this website to provide you with the best user experience. By accepting cookies, you agree to our use of cookies. Please note that if you opt not to accept or if you disable cookies, the “Your Finnegan” feature on this website will be disabled as well. For more information on how we use cookies, please see our Privacy Policy.
Finnegan is thrilled to announce the launch of our new blog, Ad Law Buzz, devoted solely to breaking news, developments, trends, and analysis in advertising law.